High mortality after ST-segment elevation myocardial infarction and implications for implantable cardioverter defibrillator trials design.
作者信息
Fauchier Laurent, Bodin Alexandre, Pierre Bertrand
机构信息
Service de Cardiologie, Centre Hospitalier Universitaire Trousseau, Avenue de la Republique, Tours 37044, France.
Faculté de Médecine, Université François Rabelais, 2 boulevard Tonnellé, Tours 37000, France.
出版信息
Europace. 2025 May 7;27(5). doi: 10.1093/europace/euaf096.
Abstract
摘要
相似文献
1
High mortality after ST-segment elevation myocardial infarction and implications for implantable cardioverter defibrillator trials design.ST段抬高型心肌梗死后的高死亡率及其对植入式心脏复律除颤器试验设计的影响。
Europace. 2025 May 7;27(5). doi: 10.1093/europace/euaf096.
2
Acute ST-Segment Elevation Myocardial Infarction as a Rare Postoperative Complication of Biventricular Implantable Cardioverter-Defibrillator Placement.急性ST段抬高型心肌梗死作为双心室植入式心脏复律除颤器植入术后的罕见并发症
JACC Case Rep. 2022 Sep 21;4(18):1195-1199. doi: 10.1016/j.jaccas.2022.06.023.
3
Strain echocardiography improves risk prediction of ventricular arrhythmias after myocardial infarction.应变超声心动图提高心肌梗死后室性心律失常的风险预测。
JACC Cardiovasc Imaging. 2013 Aug;6(8):841-50. doi: 10.1016/j.jcmg.2013.03.005. Epub 2013 Jul 10.
4
Significance of inducible very fast ventricular tachycardia (cycle length 200-230 ms) after early reperfusion for ST-segment-elevation myocardial infarction.ST 段抬高型心肌梗死早期再灌注后诱导的快速室性心动过速（周长 200-230ms）的意义。
Circ Arrhythm Electrophysiol. 2013 Oct;6(5):884-90. doi: 10.1161/CIRCEP.113.000213. Epub 2013 Aug 30.
5
Implantable cardioverter defibrillator and survival after out-of-hospital cardiac arrest due to acute myocardial infarction in Denmark in the years 2001-2012, a nationwide study.植入式心脏复律除颤器与2001年至2012年丹麦急性心肌梗死所致院外心脏骤停后的生存率：一项全国性研究
Eur Heart J Acute Cardiovasc Care. 2017 Mar;6(2):144-154. doi: 10.1177/2048872616687115. Epub 2017 Jan 6.
6
Implications for present and future applications of the implantable cardioverter-defibrillator resulting from the use of a simple model of cost efficacy.使用简单成本效益模型对植入式心脏复律除颤器当前及未来应用的启示。
Br Heart J. 1993 Jan;69(1):83-92. doi: 10.1136/hrt.69.1.83.
7
Long-term arrhythmia-free survival in patients with severe left ventricular dysfunction and no inducible ventricular tachycardia after myocardial infarction.心梗后左心室功能严重受损且无可诱发性室性心动过速患者的长期无心律失常生存。
Circulation. 2014 Feb 25;129(8):848-54. doi: 10.1161/CIRCULATIONAHA.113.005146. Epub 2013 Dec 31.
8
Outcomes of early risk stratification and targeted implantable cardioverter-defibrillator implantation after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.直接经皮冠状动脉介入治疗ST段抬高型心肌梗死后早期风险分层及靶向植入式心律转复除颤器植入的结果
Circulation. 2009 Jul 21;120(3):194-200. doi: 10.1161/CIRCULATIONAHA.108.836791. Epub 2009 Jul 6.
9
Implantable Cardioverter-Defibrillator Placement in Spontaneous Coronary Artery Dissection: A Case Report.自发性冠状动脉夹层中植入心脏转复除颤器：病例报告。
Am J Case Rep. 2024 Jun 11;25:e942579. doi: 10.12659/AJCR.942579.
10
Long-Term Outcome of the Randomized DAPA Trial.DAPA 试验的长期结果。
Circ Arrhythm Electrophysiol. 2020 Nov;13(11):e008484. doi: 10.1161/CIRCEP.120.008484. Epub 2020 Oct 1.
本文引用的文献
1
Mortality and use of implantable cardioverter defibrillators in patients with low ejection fraction following non-ST-segment elevation myocardial infarction.非ST段抬高型心肌梗死后射血分数降低患者的死亡率及植入式心脏复律除颤器的使用情况
Europace. 2025 Feb 5;27(2). doi: 10.1093/europace/euaf036.
2
Sudden cardiac death after myocardial infarction: individual participant data from pooled cohorts.心肌梗死后心源性猝死：来自汇总队列的个体参与者数据。
Eur Heart J. 2024 Nov 14;45(43):4616-4626. doi: 10.1093/eurheartj/ehae326.
3
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.2022年欧洲心脏病学会室性心律失常患者管理和心脏性猝死预防指南
Eur Heart J. 2022 Oct 21;43(40):3997-4126. doi: 10.1093/eurheartj/ehac262.
4
Ethical issues in two parallel trials of personalised criteria for implantation of implantable cardioverter defibrillators for primary prevention: the PROFID project-a position paper.两种平行试验中应用个体化植入标准的伦理学问题：植入式心脏复律除颤器一级预防的 PROFID 项目——立场文件。
Open Heart. 2021 Jul;8(2). doi: 10.1136/openhrt-2021-001686.
5
The PROFID project.PROFID项目。
Eur Heart J. 2020 Oct 14;41(39):3781-3782. doi: 10.1093/eurheartj/ehaa645.
6
Mortality and cardiac resynchronization therapy with or without defibrillation in primary prevention.在一级预防中，死亡率和心脏再同步治疗与除颤与否。
Europace. 2020 Aug 1;22(8):1224-1233. doi: 10.1093/europace/euaa096.
7
Declining Risk of Sudden Death in Heart Failure.心力衰竭患者猝死风险降低。
N Engl J Med. 2017 Jul 6;377(1):41-51. doi: 10.1056/NEJMoa1609758.
8
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.胺碘酮或植入式心脏复律除颤器用于治疗充血性心力衰竭。
N Engl J Med. 2005 Jan 20;352(3):225-37. doi: 10.1056/NEJMoa043399.
9
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.对心肌梗死且射血分数降低的患者进行预防性植入除颤器。
N Engl J Med. 2002 Mar 21;346(12):877-83. doi: 10.1056/NEJMoa013474. Epub 2002 Mar 19.
Zotero 插件